New drug AMT-676 targets Hard-to-Treat cancers in early trial
NCT ID NCT06400485
First seen May 26, 2026 · Last updated Jun 16, 2026 · Updated 8 times
Summary
This early-phase study tests a new drug called AMT-676 in about 24 adults with advanced solid tumors that have not responded to other treatments. The drug is designed to target and attack cancer cells. The main goals are to find the safest dose and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cabrini Hospital
RECRUITINGMelbourne, Victoria, Australia
-
Carolina Biooncology Institute
NOT_YET_RECRUITINGHuntersville, North Carolina, 28078, American Samoa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fujian Provincial Cancer Hospital
NOT_YET_RECRUITINGFuzhou, Fujian, 350014, China
Contact
-
Gallipoli Medical Research Foundation
RECRUITINGGreenslopes, Queensland, Australia
-
John Hopkins Sidney Kimmel Comprehensive Cancer Center
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19107, American Samoa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Linear Research
RECRUITINGNedlands, Western Australia, Australia
-
Macquarie University Hospital
RECRUITINGMacquarie, New South wWales, Australia
-
SCIENTIA Clinical Research Ltd
RECRUITINGRandwick, New South Wales, Australia
Contact Email: •••••@•••••
-
Shanghai East Hospital
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200000, China
Contact
-
Sichuan Provincial People's Hospital
NOT_YET_RECRUITINGChengdu, Sichuan, 610000, China
Contact
-
Sir Run Run Shaw Hospital
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310016, China
Contact
-
South Texas Accelerated Research Therapeutics (start) San Antonio
NOT_YET_RECRUITINGSan Antonio, Texas, American Samoa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sun Yat-sen University Cancer Center
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510060, China
Contact
Conditions
Explore the condition pages connected to this study.